From Casetext: Smarter Legal Research

United States v. Kavod Pharm.

United States District Court, E.D. Pennsylvania
Dec 16, 2022
CRIMINAL 2:19-CR-00689-RBS (E.D. Pa. Dec. 16, 2022)

Opinion

CRIMINAL 2:19-CR-00689-RBS

12-16-2022

UNITED STATES OF AMERICA v. KAVOD PHARMACEUTICALS LLC (F/K/A RISING PHARMACEUTICALS, LLC, F/K/A RISING PHARMACEUTICALS, INC.


ORDER DISMISSING INFORMATION WITH PREJUDICE

HON. R. BARCLAY SURRICK, UNITED STATES DISTRICT JUDGE

The unopposed motion of the United States to dismiss the Information filed in the above-captioned case with prejudice pursuant to Rule 48(a) of the Federal Rules of Criminal Procedure, is hereby granted. Having reviewed the motion, the Court finds as follows:

1. On December 3, 2019, the United States filed a criminal Information charging Rising with one count of conspiracy in restraint of trade in violation of Section 1 of the Sherman Act (15 U.S.C. § 1). ECF Dkt. No. 1 (“Information”).

2. On December 3, 2019, the United States also entered into a deferred prosecution agreement (“DPA”) with Rising, in which the United States deferred prosecution of Rising for a period of three years. ECF Dkt. No. 2. Among other obligations, the DPA required Rising to cooperate with the United States' investigation. Rising was also required to pay a criminal monetary penalty of $1,500,000 and restitution in the amount of $1,543,207.

3. The DPA provided that the United States would not continue the criminal prosecution against Rising and would move to dismiss the Information within thirty days of the expiration of the DPA if Rising complied fully with its obligations under the DPA. See DPA ¶ 18.

4. The DPA expired on December 3, 2022.

5. Based on the information known to the United States, Rising has met its obligations under the DPA fully, including full cooperation with the United States and satisfaction of the terms of the provisions regarding self-reporting. In addition, Rising made timely payment of the $1,500,000 criminal monetary penalty and $1,543,207 restitution.

6. Because Rising has complied fully with its obligations under the DPA, the United States has determined that dismissal of the Information with prejudice is appropriate. The United States conferred with counsel for Rising, who concurs that dismissal is appropriate at this time.

It is so ORDERED.


Summaries of

United States v. Kavod Pharm.

United States District Court, E.D. Pennsylvania
Dec 16, 2022
CRIMINAL 2:19-CR-00689-RBS (E.D. Pa. Dec. 16, 2022)
Case details for

United States v. Kavod Pharm.

Case Details

Full title:UNITED STATES OF AMERICA v. KAVOD PHARMACEUTICALS LLC (F/K/A RISING…

Court:United States District Court, E.D. Pennsylvania

Date published: Dec 16, 2022

Citations

CRIMINAL 2:19-CR-00689-RBS (E.D. Pa. Dec. 16, 2022)